Skip to main content
Qiagen N.V. logo

Qiagen N.V. — Investor Relations & Filings

Ticker · QIA ISIN · NL0015001WM6 LEI · 54930036WK3GMCN17Z57 F Manufacturing
Open in API
Filings indexed 627 across all filing types
Latest filing 2018-05-04 Interim / Quarterly Rep…
Country NL Netherlands
Listing F QIA

About Qiagen N.V.

https://www.qiagen.com/

Qiagen N.V. is a global provider of "Sample to Insight" solutions, offering technologies that transform biological materials into valuable molecular insights. The company develops and markets sample and assay technologies, automated instrumentation, and bioinformatics software for molecular diagnostics, applied testing, academic research, and pharmaceutical development. Its comprehensive portfolio supports the entire workflow from sample collection and preparation of DNA, RNA, and proteins to analysis and interpretation. Key product areas include sample preparation kits, PCR, digital PCR (dPCR), and next-generation sequencing (NGS) solutions, as well as syndromic testing panels for infectious diseases.

Recent filings

Filing Released Lang Actions
6-K
Interim / Quarterly Report Classification · 100% confidence The document is a Form 6-K filed by QIAGEN N.V. for the quarterly period ended March 31, 2018. It includes detailed unaudited condensed consolidated financial statements such as balance sheets, income statements, statements of comprehensive income, changes in equity, and cash flows, along with notes and management discussion sections. Form 6-K is used by foreign private issuers to furnish quarterly or other periodic reports to the SEC. The presence of comprehensive financial data and analysis for a quarterly period indicates this is an Interim / Quarterly Report. The document is about 15,000 characters long, contains substantive financial data, and is not merely an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2018-05-04 English
6-K
Interim / Quarterly Report Classification · 95% confidence The document is a Form 6-K filed by QIAGEN N.V. for the quarterly period ended March 31, 2018. It includes unaudited financial results for the first quarter of 2018, detailed financial data such as net sales, operating income, net income, EPS, segment sales, geographic sales, and cash flow information. The document references a press release with financial results and provides reconciliations of adjusted and GAAP figures. The presence of comprehensive financial data and analysis for a quarterly period indicates this is an Interim / Quarterly Report. Form 6-K is used by foreign private issuers to report quarterly financial results to the SEC, which aligns with the definition of an Interim / Quarterly Report (IR). The document is about 15,000 characters, which is substantial and contains actual financial statements and substantive financial data, not just an announcement or certification. Therefore, the correct classification is IR with high confidence.
2018-05-04 English
QIAGEN reports results for first quarter 2018
Earnings Release Classification · 99% confidence The document text explicitly states, "QIAGEN reports results for first quarter 2018" and provides detailed financial figures (Net sales, Operating income, EPS) for Q1 2018 compared to Q1 2017, along with management commentary on performance and outlook. This content structure—quarterly financial highlights, selected key figures tables, and management discussion—is characteristic of an Earnings Release (ER). Although it contains comprehensive data, the focus on the immediate period's results and guidance reaffirmation points strongly to an ER rather than a full, comprehensive Annual Report (10-K) or a detailed Interim/Quarterly Report (IR) which usually contains full balance sheets and cash flow statements in a standardized regulatory format, although this document is quite detailed. Given the headline and the nature of the data presented (key highlights and selected figures), 'ER' is the most appropriate classification over 'IR' or 'MDA'. The document length (45,590 chars) suggests it is more than just a brief press release, but the primary function is the announcement of period results. Q1 2018
2018-05-03 English
Annual Report 2017
Annual Report Classification · 100% confidence The document is explicitly titled 'Annual Report 2017' and contains a comprehensive table of contents covering the Supervisory Board report, Management Report, Corporate Governance, and full Consolidated Financial Statements (Balance Sheets, Income Statements, Cash Flows, etc.). It is a full-year statutory filing, not an announcement or a summary, fitting the definition of a 10-K (Annual Report). FY 2017
2018-04-11 English
IRANNOTICE
Regulatory Filings Classification · 95% confidence The document is a short notice letter addressed to the U.S. Securities and Exchange Commission referencing a disclosure made pursuant to the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act. It states that the disclosure was made in the company's Annual Report on Form 20-F for the fiscal year ended December 31, 2017, which was filed on March 5, 2018. The document itself does not contain the annual report or substantive financial data but merely notifies the SEC of the disclosure in the annual report. The document length is only 1065 characters, indicating it is a brief notice rather than a full report. According to the rules, such a document is a Regulatory Filing (RNS) as it is a compliance notice referencing a report rather than the report itself.
2018-03-05 English
20-F
Annual Report FY 2017
2018-03-05 English

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.